| |
| |
|
| Insider
Information: |
Hyde Joseph R III |
| Relationship: |
Director |
| City: |
Memphis |
| State: |
TN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
4,411,298 |
|
|
Indirect Shares
|
2,672,247 |
|
|
| Direct
Value |
$237,950,737 |
|
|
|
Indirect Value
|
$6,586,467 |
|
|
| Total
Shares |
7,083,545 |
|
|
| Total
Value |
$244,537,203 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Fedex Corp |
FDX |
Director |
2009-04-29 |
132,000 |
2008-11-03 |
0 |
Premium* |
|
|
Oncternal Therapeutics Inc |
ONCT |
Director, 10% Owner |
2019-01-02 |
4,207,368 |
2019-01-02 |
2,670,247 |
Premium* |
|
|
Autozone Inc |
AZO |
Director |
2018-01-01 |
71,930 |
2018-01-01 |
2,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
178 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2013-04-01 |
4 |
A |
$4.04 |
$13,625 |
D/D |
3,373 |
9,405,014 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2010-01-01 |
4 |
A |
$4.20 |
$10,500 |
D/D |
2,500 |
6,375,162 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2013-01-01 |
4 |
A |
$4.20 |
$16,375 |
D/D |
3,899 |
9,132,861 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2012-10-01 |
4 |
A |
$4.58 |
$8,250 |
D/D |
1,801 |
9,957,410 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2011-06-28 |
4 |
B |
$4.75 |
$4,631,250 |
D/D |
975,000 |
10,709,882 |
3.92 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2011-07-01 |
4 |
A |
$4.79 |
$8,250 |
D/D |
1,722 |
10,941,802 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2017-04-03 |
4 |
A |
$4.90 |
$15,625 |
D/D |
3,189 |
2,075,287 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2017-01-03 |
4 |
A |
$5.21 |
$15,625 |
D/D |
2,999 |
4,322,099 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2013-07-01 |
4 |
A |
$6.62 |
$13,625 |
D/D |
2,058 |
9,590,371 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
officerTitle |
– • • |
2005-12-06 |
4 |
B |
$7.44 |
$744,000 |
D/D |
100,000 |
7,441,342 |
3.92 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
officerTitle |
– • • |
2006-01-01 |
4 |
A |
$7.56 |
$5,000 |
D/D |
661 |
7,442,004 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2005-10-11 |
4 |
B |
$7.80 |
$3,900,000 |
I/I |
500,000 |
677,000 |
2.25 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2005-10-11 |
4 |
B |
$7.80 |
$5,850,000 |
D/D |
750,000 |
8,756,855 |
3.92 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2017-10-02 |
4 |
A |
$7.94 |
$15,625 |
D/D |
1,968 |
3,983,530 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2004-08-13 |
4 |
B |
$8.22 |
$43,628 |
I/I |
5,000 |
127,000 |
2.25 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2004-08-16 |
4 |
B |
$8.50 |
$765,000 |
I/I |
90,000 |
114,350 |
2.25 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2004-08-06 |
4 |
B |
$8.76 |
$88,739 |
I/I |
10,000 |
112,000 |
2.25 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2004-08-09 |
4 |
B |
$8.86 |
$89,896 |
I/I |
10,000 |
122,000 |
2.25 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2004-08-05 |
4 |
B |
$8.94 |
$44,704 |
I/I |
5,000 |
102,000 |
2.25 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2009-03-10 |
4 |
B |
$8.95 |
$101,289 |
D/D |
11,323 |
7,641,450 |
3.92 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2004-08-04 |
4 |
B |
$8.96 |
$135,222 |
I/I |
15,000 |
97,000 |
2.25 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2005-04-01 |
4 |
A |
$9.10 |
$5,000 |
D/D |
549 |
8,005,815 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2006-07-01 |
4 |
A |
$9.10 |
$5,000 |
D/D |
549 |
6,943,011 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2009-07-01 |
4 |
A |
$9.23 |
$8,250 |
D/D |
894 |
7,708,477 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2006-10-01 |
4 |
A |
$9.24 |
$5,000 |
D/D |
541 |
6,943,552 |
0 |
- |
|
178 Records found
|
|
Page 4 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
